Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Director Clinical Trial Disclosure Simnova Director Clinical Trial Disclosure Simnova
CONTACT
Lead
Shanghai Simnova Biotechnology Co.,Ltd.
Approximately up to about 50 participants with moderate-to-severe refractory systemic lupus erythematosus are planned to enroll. This study is divided into two stages: dose escalation and dose extension.
Age
18–65
Sex
ALL
Healthy volunteers
Not accepted